FCGR2B and Behcet disease: A recent study demonstrated a perturbed FcγRs balance in monocytes from BD patients that represented downregulated inhibitory FcγRIIb and upregulated activating FcγRIII, the level of which fluctuated along with BD treatment and disease severity.